Abstract
Loss to follow-up (LTFU) after newborn hearing screening (NHS) is a persistent, internationally documented barrier to diagnosis and intervention. This cohort study evaluated diagnostic follow-up after NHS among well infants at a tertiary hospital in Jordan (February 2024–February 2025) and examined factors associated with initial OAE referral. Well newborns underwent otoacoustic emission (OAE) screening at birth; those who did not pass were scheduled for repeat OAE at 2 weeks and diagnostic auditory brainstem response (ABR) evaluation at 2 months when indicated. Among 1074 screened infants, 100 (9.3%) did not pass initial OAE, and 26 (26.0%) returned for repeat testing (LTFU = 74.0%). Of 57 infants meeting criteria for diagnostic ABR, 3 (5.3%) completed evaluation (LTFU = 94.7%); no tested factor predicted initial OAE referral, and ABR- LTFU predictors could not be analyzed. Most families with incomplete evaluation (72%) could not be reached because contact information recorded at screening was inaccurate or outdated; barriers among families reached included perceived normal hearing, financial constraints, and difficulty accessing the clinic. Although poor diagnostic follow-up is a documented challenge across high-, middle-, and low-income settings, the LTFU observed here (74.0–94.7%) was higher than international averages and comparable to the upper range reported among programs lacking systemic tracking infrastructure, underscoring the absence of a dedicated follow-up and recall system as the primary driver. Establishing centralized data tracking, structured recall procedures, and parental education are essential to closing this gap.